CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0001 (-44.44%)
Jul 7, 2026, 12:03 PM EST
CNBX Pharmaceuticals Employees
CNBX Pharmaceuticals had 1 employees as of May 31, 2026. The number of employees did not change compared to the same quarter last year.
Employees
1
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$462,091
Market Cap
321.15K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| May 31, 2026 | 1 | 0 | - |
| Feb 28, 2026 | 1 | 0 | - |
| Aug 31, 2025 | 1 | -1 | -50.00% |
| Feb 28, 2025 | 1 | -1 | -50.00% |
| Aug 31, 2024 | 2 | 0 | - |
| Feb 29, 2024 | 2 | -1 | -33.33% |
| Aug 31, 2023 | 2 | -3 | -60.00% |
| Feb 28, 2023 | 3 | - | - |
| Nov 30, 2022 | 5 | -5 | -50.00% |
| Aug 31, 2022 | 5 | -5 | -50.00% |
| Aug 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IO Biotech | 78 |
| Carisma Therapeutics | 46 |
| Altamira Therapeutics | 11 |
| Ampio Pharmaceuticals | 6 |
| Innovation Pharmaceuticals | 4 |
| GB Sciences | 2 |
| Actavia Life Sciences | 1 |
CNBX Pharmaceuticals News
- 3 years ago - CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma - PRNewsWire
- 4 years ago - CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy - PRNewsWire
- 4 years ago - CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel - PRNewsWire
- 4 years ago - CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate - PRNewsWire
- 4 years ago - CNBX Pharmaceuticals Announces New Patent Granted in Australia - PRNewsWire
- 4 years ago - CNBX Pharmaceuticals Granted Patent in Hong Kong - PRNewsWire
- 4 years ago - Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals - PRNewsWire
- 5 years ago - CNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase I/II (a) Clinical Trials - PRNewsWire